3 completed, 2 terminated, 1 active not recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Terminated 2, Active not recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Hodgkins Lymphoma: new trials by email Literature Review of Hodgkins Lymphoma trials Research Report on Hodgkins Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies Ossium HPC Marrow, Bone Marrow Transplant, Pre-transplant conditioning - Myeloablative (MAC), Pre-transplant conditioning - Reduced Intensity (RIC) - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | Ossium Health, Inc. | 12 | 2024-08-16 | 2026-09-10 |
| Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma allogeneic donor derived LMP specific cytotoxic T-lymphocyte - Hodgkins Lymphoma | Phase 2 | Terminated | New York Medical College | 2 | 2013-01-01 | 2017-12-22 |
| Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning Fludarabine monophosphate, Busulfan, Stem Cell Infusion - Leukemia, Acute Myeloid Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 201 | 2012-04-11 | 2023-06-29 |
| Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies Oncaspar, Doxil, Decadron - Non-hodgkins Lymphoma, Hodgkins Lymphoma | Phase 2 | Terminated | Milton S. Hershey Medical Center | 13 | 2009-03-01 | 2017-07-24 |
| Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft - Leukemia, Myelodysplastic Syndrome | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 86 | 2008-08-12 | 2022-12-08 |
| Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma 8 cycles BEACOPPesc plus oral contraceptive, 8 cycles BEACOPPesc plus Goserelin - Hodgkins Lymphoma | Phase 2 | Completed | University of Cologne | 60 | 2004-01-01 | 2012-06-25 |
Hodgkin Disease (6) · Leukemia (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3) · Lymphoma, Non-Hodgkin (3) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Hematologic Diseases (1) · Leukemia, B-Cell (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, T-Cell, Cutaneous (1)
Hemic and Lymphatic Diseases (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Lymphoma (4) · Bone Marrow Diseases (3) · Chronic Disease (3) · Disease Attributes (3) · Hematologic Diseases (3) · Leukemia, Myeloid (3) · Myeloproliferative Disorders (3) · Pathologic Processes (3)
Cyclophosphamide (2) · Filgrastim (2) · fludarabine phosphate (2) · Bone Marrow Transplantation (1) · Busulfan (1) · Calcium Dobesilate (1) · Contraceptives, Oral (1) · Goserelin (1) · Granulocyte Colony-Stimulating Factor (1) · Melphalan (1) · Mesna (1) · Methotrexate (1) · Mycophenolic Acid (1) · Radiotherapy (1) · Tacrolimus (1)
M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · Milton S. Hershey Medical Center (1) · New York Medical College (1) · Ossium Health, Inc. (1) · University of Cologne (1)
United States (5)
Joseph J. Drabick, MD (1) · Juliet Barker, MBBS (1) · Mitchell S Cairo, MD (1) · Uday Popat, MD (1)